Proven Leaders in Advancing Life Science.
Investing in life science with the goal of improving the lives of patients, while delivering superior results to investors.
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. We operate three lines of business: Pappas Ventures, our flagship venture arm; Specialized Fund Management, where we create and manage custom-tailored investment vehicles; and Translational Medicine, where we partner with research universities to accelerate the development of their scientific discoveries and inventions.
Our in-depth industry knowledge gives Pappas Capital a comprehensive understanding of the uncertain pathway that life science companies must travel in their pursuit of success.
With longstanding relationships throughout the industry, we’re able to help our portfolio companies find talent for their teams. Our deep understanding of the drug development process enables our management teams to provide insightful guidance and craft effective clinical and regulatory strategies. We also endeavor to accelerate the progress of our companies by leveraging our extensive professional network.
We believe strongly in supporting our local community through charitable giving in the realms of life science, public education and other entrepreneurial endeavors.
Creating, guiding, connecting and funding innovative life science companies, from concept to commercialization.
Structuring and managing customized life science investment vehicles to meet the strategic needs of our investors.
Partnering with leading academic institutions to accelerate the development of research discoveries and inventions.